JAZZ vs MBAVW · P/E 1988, rev $2.28B vs $10.1M cap
Jazz Pharmaceuticals PLC (JAZZ) versus M3-Brigade Acquisition V Corp. Warrant (MBAVW) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
M3-Brigade Acquisition V Corp. Warrant (MBAVW) common stock listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
MBAVW does not have a complete income-statement cache yet.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MBAVW currently screens at market cap $10.1M.
Not investment advice. Open the JAZZ and MBAVW stock pages for the full models.
Not investment advice.